EM-1421

EM-1421 · Erimos Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EM-1421, covering 2008-01-24 to 2016-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia [Phase 1, Phase 2]